Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Gut Liver. 2012 Jul;6(3):349-54. doi: 10.5009/gnl.2012.6.3.349. Epub 2012 Jul 12.
BACKGROUND/AIMS: Solid organ transplant recipients frequently report gastrointestinal symptoms, especially heartburn or dyspepsia. However, the prevalence of endoscopic erosive esophagitis (EE) and associated risk factors after transplantation are unknown. The aim of this study was to determine whether there was a high incidence of endoscopic findings of EE in solid organ transplant recipients.
This retrospective case-control study included 256 of 3,152 solid organ transplant recipients who underwent sequential screening upper endoscopic examinations and an equal number of controls.
Forty-four (17.2%) and 16 (6.2%) cases of EE were detected in the solid organ transplant and control groups, respectively (p<0.001). In the multivariate analysis, transplantation was significantly associated with EE (odds ratio [OR], 6.48; 95% confidence interval, 2.74 to 15.35). Factors such as old age (OR, 1.17), the presence of a hiatal hernia (OR, 5.84), an increased duration of immunosuppression (OR, 1.07), and the maintenance administration of mycophenolate mofetil (OR, 4.13) were independently associated with the occurrence of EE in the solid organ transplant recipients.
A significant increase in the incidence of endoscopically detected EE was observed in solid organ transplant recipients. This increased incidence was associated with the type and duration of the immunosuppressive therapy.
背景/目的:实体器官移植受者经常报告胃肠道症状,尤其是烧心或消化不良。然而,移植后内镜下糜烂性食管炎(EE)的患病率及其相关危险因素尚不清楚。本研究旨在确定实体器官移植受者中是否存在内镜 EE 发现的高发生率。
这项回顾性病例对照研究纳入了 256 名接受连续筛查上内镜检查的 3152 名实体器官移植受者,以及数量相等的对照组。
在实体器官移植组和对照组中分别检测到 44 例(17.2%)和 16 例(6.2%)EE(p<0.001)。多变量分析显示,移植与 EE 显著相关(优势比 [OR],6.48;95%置信区间,2.74 至 15.35)。年龄较大(OR,1.17)、存在食管裂孔疝(OR,5.84)、免疫抑制治疗时间延长(OR,1.07)和麦考酚酸酯的维持治疗(OR,4.13)等因素与实体器官移植受者 EE 的发生独立相关。
在实体器官移植受者中,内镜下检测到 EE 的发生率显著增加。这种发生率的增加与免疫抑制治疗的类型和持续时间有关。